Future large long-term RCTs with primary or secondary outcomes, including thyroid disorders and real-world data, are needed to elucidate the association between GLP-1 receptor agonists and the risk of various thyroid disorders, particularly thyroid cancer
This means women who previously had infrequent periods may suddenly experience more regular menstruation, which, whilst positive for fertility and metabolic health, can be unexpected
Who It's For Those seeking both recovery benefits and anti-aging effects
Some insurers mandate a trial of oral semaglutide before approving injectable GLP-1 agents
Circulation 119:28182828
Eli Lilly, which makes Mounjaro, warns that gallstones may affect up to one in 10 people taking the drug for weight loss, listing them as a common side effect in its patient information leaflet